Statistics for MMG22: A Novel Bivalent Ligand for the Treatment of Neuropathic Pain

Total visits

views
MMG22: A Novel Bivalent Ligand for the Treatment of Neuropathic Pain 95

Total visits per month

views
May 2024 1
June 2024 0
July 2024 3
August 2024 1
September 2024 1
October 2024 3
November 2024 0

File Visits

views
SpeltzPaiz_umn_0130E_22872.pdf 233

Top country views

views
United States 40
China 8
India 7
Australia 4
Belgium 4
Canada 4
Turkey 4
Egypt 3
Hong Kong SAR China 3
Ireland 3
South Korea 3
France 2
Russia 2
Belarus 1
Germany 1
Estonia 1
Indonesia 1
Malaysia 1
Singapore 1
Thailand 1

Top city views

views
Minneapolis 5
Brussels 4
Chicago 4
Ankara 3
Baltimore 3
Cairo 3
St Louis 3
Boardman 2
Dublin 2
Durham 2
Saint-Sébastien-sur-Loire 2
Seattle 2
Seongbuk-gu 2
Tseung Kwan O 2
Ashburn 1
Atlanta 1
Bangkok 1
Champlin 1
Chennai 1
Coimbatore 1
College Point 1
Des Moines 1
Fremont 1
Grimsby 1
Highton 1
Istanbul 1
Jakarta 1
Khimki 1
Layton 1
Los Angeles 1
Maple Grove 1
Minsk 1
Montreal 1
New York 1
Oakland 1
Olympia 1
Providence 1
Roscommon 1
Saint Lucia 1
Saint Paul 1
San Antonio 1
San Jose 1
Shah Alam (Hicom-glenmarie Industrial Park) 1
Singapore 1
Tallinn 1
The Bronx 1
Toronto 1
Valley Stream 1
Vijayawada 1
Wendouree 1
Xi'an 1
Yelahanka 1
Zhengzhou 1